...Okay. Great. I'm Yigal Nochomovitz. I'm one of the biotech analysts at Citi. This is Citi's Virtual Oncology Leadership Summit. It's my pleasure to have with me senior management from Arvinas, Ron Peck as well as Ian Taylor. Ron, Ian, thanks so much for taking the time to chat. Great to have you. So maybe at a high level, I think, obviously, a lot of people are very familiar with the Arvinas story, but if you could just give a quick 2- to 3-minute overview of the platform in protein degradation in the PROTAC space. And what are the key features that make Arvinas stand out in the protein degradation world relative to some of the other players. Thanks. Ian Taylor ...
